SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is the top trending stock as investors fiercely debate whether its upcoming earnings will validate the immense AI sector enthusiasm or trigger a 'sell the news' event, with many believing its performance will heavily influence the broader market's short-term direction.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending following recent partnerships with VAST Data and EHC Investment for advanced AI data center solutions, and ahead of anticipated NVIDIA earnings that could further boost the AI infrastructure sector. The community is actively discussing the stock's undervaluation, anticipating a potential short squeeze, and largely dismissing bearish analyst calls amidst perceived market manipulation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as Warner Bros. Discovery considers a higher bid from Paramount Skydance, putting pressure on Netflix to either counter or exit the contentious acquisition. Shareholders are actively debating if walking away to secure a substantial breakup fee is the better strategic move, freeing the company from potential debt and regulatory hurdles.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is seeing a significant surge following robust Q4 earnings, which highlighted strong growth in USDC adoption and transaction volumes. This positive report is triggering a notable short squeeze and widespread bullish sentiment, though some investors are cautioning about potential profit-taking and expressing concerns regarding its valuation.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is trending following FDA Breakthrough Therapy Designation for its Friedreich's ataxia treatment, nomlabofusp, which showed compelling efficacy in clinical trials and is now on a path towards accelerated approval. The community is debating the drug's strong outcomes against manageable safety concerns, while analysts are boosting price targets, signaling significant long-term potential for this rare disease therapy.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending following a notable stock decline, igniting community debate around whether AI advancements, like Anthropic's recent acquisition, represent a competitive threat or validate its strategic position as an AI orchestration platform, with many investors anticipating a rebound driven by strong fundamentals and upcoming earnings.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community eagerly discusses its new 10 kW DC-DC power platform, which promises 98.5% efficiency for next-gen AI data centers, with many anticipating major contracts from hyperscalers like NVIDIA. Investors are debating whether its innovative GaN and SiC technology will soon translate into significant revenue growth, given current low revenue figures and a high market valuation without definitive deals.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is actively discussed by investors anticipating a catalytic impact from upcoming NVIDIA earnings on the broader AI infrastructure sector, often contrasted with competitor CoreWeave, while aggressive call buying and recent analyst price target upgrades fuel strong bullish sentiment amid ongoing debate about its financial performance and a potential short squeeze.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending due to robust earnings that surpassed expectations, paired with an upbeat FY26 outlook for same-store sales and new restaurant expansion, fueling strong bullish sentiment. The community is actively discussing its premium valuation and growth potential, with bulls comparing it favorably to competitors like Chipotle, while bears highlight persistent margin pressures and a high P/E ratio.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is actively discussed following its report of robust revenue growth and record contract value, alongside expanding AI-driven partnerships in precision oncology. Despite mixed views on its path to profitability and valuation, high short interest and notable investor accumulation are fueling speculation of a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurogene Maps NGN-401 Pivotal Rett Timeline, Mid-2026 Data Update at Guggenheim Summit

Neurogene (NASDAQ:NGNE) is advancing a genetic medicines pipeline focused on rare neurologic diseases, with its lead program NGN-401 aimed at treating Rett syndrome, President and CFO Christine...

Neurogene to Participate in Upcoming Investor Conferences

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company...

Neurogene (NASDAQ:NGNE) Now Covered by Analysts at Lifesci Capital

Lifesci Capital initiated coverage on shares of Neurogene in a research note on Monday. They issued an "outperform" rating and a $50.00 price target for the company...

Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Analysts

Neurogene Inc. (NASDAQ:NGNE - Get Free Report) has received a consensus rating of "Hold" from the seven ratings firms that are covering the stock, Marketbeat reports. One equities research analyst...

Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today provided an update on...

Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Brokerages

Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been given an average rating of "Hold" by the seven ratings firms that are currently covering the company, MarketBeat.com reports. One...

Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Recommendation of "Hold" from Brokerages

Neurogene Inc. (NASDAQ:NGNE - Get Free Report) has received an average recommendation of "Hold" from the seven brokerages that are covering the company, MarketBeat.com reports. One analyst has rated...

Neurogene (NASDAQ:NGNE) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen downgraded Neurogene from a "hold" rating to a "sell" rating in a research report on Saturday...

Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Hold" by Brokerages

Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been assigned an average recommendation of "Hold" from the seven analysts that are covering the firm, MarketBeat Ratings reports. One...

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.

Neurogene Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

Current Price	$19.85
Prev Close	$18.90
Open	$19.40
Dividend Yield	0.00%
50-Day Moving Average	$18.70
Beta	1.47
Avg. Volume	145,561.05
PE Ratio	-4.27

52-Week High	$37.27
52-Week Low	$6.88
Market Capitalization	$292.76M
EPS (Annual)	-$4.28
Price to Book	1.05
Revenue Per Employee	$8,644.86

NGNE
Neurogene Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NGNE News

NGNENeurogene Inc